Meihua International Announces 1-For-100 Reverse Share Split
Meihua International (Nasdaq: MHUA) will effect a 1-for-100 reverse share split and implement a dual-class share structure effective at market open on November 24, 2025. Class A ordinary shares will carry a new par value of $0.05, trade under the same symbol with new CUSIP G5966G116, and no fractional shares will be issued (fractions rounded up).
The split reduces issued Class A shares from ~56 million to ~0.56 million, applies to outstanding derivative securities with proportionate adjustments, and was approved by shareholders on November 8, 2025. VStock Transfer is exchange and paying agent; brokerage-held shares require no action.
Meihua International (Nasdaq: MHUA) effettuerà una reverse share split 1-for-100 e implementerà una struttura a due classi di azioni con effetto all'apertura del mercato il 24 novembre 2025. Le azioni ordinarie di Classe A avranno un nuovo valore nominale di $0,05, verranno negoziate con lo stesso simbolo con il nuovo CUSIP G5966G116, e non saranno emesse azioni frazionarie (le frazioni verranno arrotondate all'unità).
Lo split riduce le azioni emesse di Classe A da circa 56 milioni a circa 0,56 milioni, si applica ai titoli derivati in circolazione con adeguamenti proporzionali, ed è stato approvato dagli azionisti l'8 novembre 2025. VStock Transfer è l'agente di scambio e pagamenti; le azioni detenute dalle case di intermediazione non richiedono alcuna azione.
Meihua International (Nasdaq: MHUA) efectuará una reversión de valor de 1 por 100 y implementará una estructura de acciones de clase dual que entrará en vigencia a la apertura del mercado el 24 de noviembre de 2025. Las acciones ordinarias de Clase A tendrán un nuevo valor nominal de $0,05, se comercializarán bajo el mismo símbolo con el nuevo CUSIP G5966G116, y no se emitirán acciones fraccionarias (las fracciones se redondearán hacia arriba).
La división reduce las acciones emitidas de Clase A de aproximadamente 56 millones a aproximadamente 0,56 millones, se aplica a valores derivados en circulación con ajustes proporcionados, y fue aprobada por los accionistas el 8 de noviembre de 2025. VStock Transfer es la entidad de intercambio y agente pagador; las acciones en poder de corredores no requieren acción.
Meihua International (나스닥: MHUA)는 1대 100 역주식 분할을 실시하고 시장 개장 시점에 2025년 11월 24일로 시행되는 이중 클래스 주식 구조를 도입합니다. 클래스 A 보통주는 새로운 액면가 $0.05를 가지며, 같은 기호로 거래되되 새로운 CUSIP G5966G116으로 표기되며, 소수 주식은 발행되지 않습니다(소수점은 올림).
분할은 발행된 클래스 A 주식을 약 5600만 주에서 약 56만 주으로 감소시키고, 현존 파생증권에도 비례 조정이 적용되며, 주주들의 승인을 받았습니다(2025년 11월 8일). VStock Transfer는 거래 및 지급 에이전트이며; 중개가 보유한 주식은 아무 조치도 필요하지 않습니다.
Meihua International (Nasdaq: MHUA) procédera à une réunion d'actions inverse 1 pour 100 et mettra en place une structure d'actions à double classe effective à l'ouverture du marché le 24 novembre 2025. Les actions ordinaires de classe A auront une nouvelle valeur nominale de $0,05, seront négociées sous le même symbole avec le nouveau CUSIP G5966G116, et aucune action fractionnaire ne sera émise (les fractions seront arrondies à l'unité).
La scission réduit les actions émises de Classe A d'environ 56 millions à environ 0,56 million, s'applique aux valeurs dérivées en circulation avec des ajustements proportionnels, et a été approuvée par les actionnaires le 8 novembre 2025. VStock Transfer est la société d'échange et l'agent payeur; les actions détenues par les courtiers ne nécessitent aucune action.
Meihua International (Nasdaq: MHUA) wird eine 1-zu-100-Rückwärtsaktienzusammenführung durchführen und eine Dualklassen-Staatsstruktur einführen, gültig ab Handelsbeginn am 24. November 2025. Die Stammaktien der Klasse A werden einen neuen Nennwert von $0,05 tragen, werden unter demselben Symbol mit der neuen CUSIP G5966G116 gehandelt, und es werden keine Bruchteile von Aktien ausgegeben (Bruchteile werden nach oben gerundet).
Der Split reduziert die ausgegebenen Aktien der Klasse A von ca. 56 Millionen auf ca. 0,56 Millionen, gilt für ausstehende derivative Wertpapiere mit proportionale Anpassungen, und wurde von den Aktionären am 8. November 2025 genehmigt. VStock Transfer ist Austausch- und Zahlstelle; Aktien im Besitz von Brokern erfordern keine Maßnahmen.
Meihua International (ناسداك: MHUA) ستنفذ تقسيم أسهم عكسي بنسبة 1 إلى 100 وتنفذ هيكل أسهم ذو فئتين اعتباراً من افتتاح السوق في 24 نوفمبر 2025. ستملك أسهم فئة A العادية قيمة اسمية جديدة قدرها $0.05، وتُتداول بنفس الرمز مع CUSIP الجديد G5966G116، ولن تُصدر أسهم كسور (تُقرّب الكسور إلى الأعلى).
يقلل التقسيم عدد أسهم فئة A المصدرة من نحو 56 مليون إلى نحو 0.56 مليون، وينطبق على الأوراق المشتقة القائمة مع تعديلات نسبية، ووافق عليه المساهمون في 8 نوفمبر 2025. VStock Transfer هي وكيل التبادل والدفع؛ الأسهم المحتفظ بها لدى الوسطاء لا تتطلب أي إجراء.
- Reverse split effective Nov 24, 2025 to regain Nasdaq compliance
- Issued Class A shares reduced from ~56M to ~0.56M
- Outstanding derivative exercise prices and share counts will be adjusted proportionately
- Class A share par value increases to $0.05, changing share nominal terms
Insights
Meihua will implement a 1-for-100 reverse split and dual-class structure to regain Nasdaq listing compliance effective
Meihua International will perform a 1-for-100 reverse share split and adopt a dual-class share structure effective at the open of business on
The corporate mechanism is straightforward: the reverse split increases the per-share nominal share size to address the Nasdaq minimum bid-price requirement of
Items to watch: successful commencement of trading under the new CUSIP and class structure on
YANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that it would effectuate a reverse share split of its outstanding ordinary shares, par value of
Following the reverse share split, the Company’s class A ordinary shares will have a new par value of
No fractional shares will be issued in connection with the reverse share split and all such fractional interests will be rounded up to the nearest whole number of Class A Ordinary Shares. In addition, the reverse share split will apply to the Class A Ordinary Shares issuable upon the exercise of the Company’s outstanding derivative securities, with proportionate adjustments to be made to the exercise prices and number of derivates thereof and under the Company’s equity incentive plans.
The reverse share split will reduce the number of issued and outstanding shares of the Company’s Class A Ordinary Shares from approximately 56 million to approximately 0.56 million.
On November 8, 2025, the shareholders of the Company approved the proposed reverse share split and the dual-class share structure.
VStock Transfer, LLC is acting as the exchange agent and paying agent for the reverse share split. Shareholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse share split.
VStock Transfer, LLC will provide instructions to any shareholders with certificates regarding the process in connection with the exchange of pre-reverse share split share certificates for ownership in book-entry form or share certificates on a post-reverse share split basis. Shareholders are encouraged to contact their bank, broker or custodian with any procedural questions.
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. is a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China. The Company manufactures and sells Class I disposable medical devices, such as HDPE bottles for tablets and LDPE bottles for eye drops, throat strips, and anal bags, and Class II and III disposable medical devices, such as disposable identification bracelets, gynecological examination kits, inspection kits, surgical kits, medical brushes, medical dressing, medical catheters, uterine tissue suction tables, virus sampling tubes, disposable infusion pumps, electronic pumps and anesthesia puncture kits, among other products which are sold under the Company's own brands and are also sourced and distributed from other manufacturers. The Company has received an international "CE" certification and ISO 13485 system certification and has also registered with the FDA (registration number: 3006554788) for over 20 Class I products. The Company has served hospitals, pharmacies, medical institutions and medical equipment companies for more than 30 years, providing over 1,000 types of products for domestic sales, as well as over 120 products which are exported to more than 30 countries internationally across Europe, North America, South America, Asia, Africa and Oceania.
For more information, please visit www.meihuamed.com.
Follow us on Webull: https://www.webull.com/quote/nasdaq-mhua.
Forward-Looking Statements
The statements in this press release regarding the Company’s future expectations, plans and prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding plans, goals, objectives, strategies, future events, expected performance, assumptions and any other statements of fact that have not occurred. Any statements that contain the words “may”, “will”, “want”, “should”, “believe”, “expect”, “anticipate”, “estimate”, “calculate” or similar statements that are not factual in nature are to be considered forward-looking statements. Actual results may differ materially from historical results or from those expressed in these forward-looking statements as a result of a variety of factors. These factors include, but are not limited to, the Company’s strategic objectives, the Company’s future plans, market demand and user acceptance of the Company’s products or services, technological advances, economic trends, the growth of the trucking services market in China, the Company’s reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, fluctuations in China’s macroeconomic conditions, and the risks and assumptions disclosed in the Company’s reports provided to the CSRC (China Security Regulatory Commission). The potential acquisition involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements including but not limited to statements about the potential benefits of the potential acquisition; the anticipated timing of closing of the potential acquisition (including failure to obtain necessary regulatory approvals) and the possibility that the potential acquisition does not close; risks related to the ability to realize the anticipated benefits of the potential acquisition, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; disruption from the potential acquisition making it more difficult to maintain business and operational relationships; negative effects of announcing the potential acquisition or the consummation of the potential acquisition on the market price of our common stock or operating results; costs associated with the potential acquisition; unknown liabilities; and the risk of litigation and/or regulatory actions related to the potential acquisition. For these and other related reasons, we advise investors not to place any reliance on these forward-looking statements, and we urge investors to review the Company’s relevant SEC filings for additional factors that may affect the Company’s future results of operations. The Company undertakes no obligation to publicly revise these forward-looking statements subsequent to the filing of these documents as a result of changes in particular events or circumstances.
For further information, please contact.
IR Department
Email: secretary@meihuamed.com
Tel: +86-0514-89800199
FAQ
What is the reverse split ratio for Meihua (MHUA) and when does it take effect?
How many Meihua (MHUA) Class A shares will be outstanding after the split?
Will Meihua (MHUA) remain listed on Nasdaq after the reverse split?
What happens to fractional Meihua (MHUA) shares after the 1-for-100 split?
Will Meihua (MHUA) option holders see changes after the reverse split?
Do Meihua (MHUA) shareholders need to act to receive post-split shares?
What is the new CUSIP for Meihua (MHUA) Class A shares after the split?
